Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
L Ruepert, AO Quartero, NJ de Wit… - Cochrane database …, 2011 - cochranelibrary.com
Cochrane database of systematic reviews, 2011•cochranelibrary.com
Background Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder.
The role of pharmacotherapy for IBS is limited and focused mainly on symptom control.
Objectives The objective of this systematic review was to evaluate the efficacy of bulking
agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
The role of pharmacotherapy for IBS is limited and focused mainly on symptom control.
Objectives The objective of this systematic review was to evaluate the efficacy of bulking
agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
Background
Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder. The role of pharmacotherapy for IBS is limited and focused mainly on symptom control.
Objectives
The objective of this systematic review was to evaluate the efficacy of bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
cochranelibrary.com